Online citations, reference lists, and bibliographies.

Optical Improvements In The Diagnosis Of Bladder Cancer: Implications For Clinical Practice

Tina Schubert, Steffen Rausch, Omar Fahmy, Georgios Gakis, Arnulf Stenzl
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Background For over 100 years white-light cystoscopy has remained the gold-standard technique for the detection of bladder cancer (BCa). Some limitations in the detection of flat lesions (CIS), the differentiation between inflammation and malignancy, the inaccurate determination of the tumor margin status as well as the tumor depth, have led to a variety of technological improvements. The aim of this review is to evaluate the impact of these improvements in the diagnosis of BCa and their effectiveness in clinical practice. Methods A systematic literature search was conducted according to the PRISMA statement to identify studies reporting on imaging modalities in the diagnosis of NMIBC between 2000 and 2017. A two-stage selection process was utilized to determine eligible studies. A total of 74 studies were considered for final analysis. Results Optical imaging technologies have emerged as an adjunct to white-light cystoscopy and can be classified according to their scope as macroscopic, microscopic and molecular. Macroscopic techniques including photodynamic diagnosis (PDD), narrow-band imaging (NBI) and the Storz Professional Image Enhancement System (IMAGE1 S, formerly known as SPIES) are similar to white-light cystoscopy, but are superior in the detection of bladder tumors by means of contrast enhancement. Especially the detection rate of very mute lesions in the bladder mucosa (CIS) could be significantly increased by the use of these methods. Microscopic imaging techniques like confocal laser endomicroscopy and optical coherence tomography permit a real-time high-resolution assessment of the bladder mucosa at a cellular and sub-cellular level with spatial resolutions similar to histology, enabling the surgeon to perform an ‘optical biopsy’. Molecular techniques are based on the combination of optical imaging technologies with fluorescence labeling of cancer-specific molecular agents like antibodies. This labeling is intended to favor an optical distinction between benign and malignant tissue. Conclusions Optical improvements of the standard white-light cystoscopy have proven their benefit in the detection of BCa and have found their way into clinical practice. Especially the combination of macroscopic and microscopic techniques may improve diagnostic accuracy. Nevertheless, HAL-PDD guided cystoscopy is the only approach approved for routine use in the diagnosis of BCa by most urological associations in the EU and USA to date.
This paper references
10.1007/s11255-011-0036-5
Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a “second look” matters?
Yi-jun Shen (2011)
Detection and clinical outcome of urinary bladder
A Stenzl
10.1016/j.eururo.2013.07.007
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Michael Rink (2013)
10.1007/s00120-014-3557-6
Elektiver Organ- und Funktionserhalt beim Harnleiter- und Nierenbeckentumor
Sahra Rausch (2014)
10.1002/cncr.25523
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Arnulf Stenzl (2011)
10.1089/end.2012.0549
Interobserver agreement of confocal laser endomicroscopy for bladder cancer.
Timothy Chang (2013)
10.1016/j.juro.2007.03.028
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Yves Fradet (2007)
10.1016/j.urology.2009.06.088
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Maximilian Burger (2009)
10.1126/scitranslmed.3009457
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Ying Pan (2014)
10.1053/hupa.2001.24999
Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.
Stephen J. Cina (2001)
10.1089/end.2012.1556
Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients.
Seiji Prof Naito (2013)
10.1007/s00345-015-1485-8
Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy
Georgios Gakis (2015)
10.3322/caac.21332
Cancer statistics, 2016
Rebecca L. Siegel Mph (2016)
10.3233/BLC-160048
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
Ashish M. Kamat (2016)
10.3322/caac.21332
Cancer statistics, 2016.
Rebecca L Siegel (2016)
10.1016/j.juro.2007.03.034
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Herbert Barton Grossman (2007)
10.1021/ac100448p
In vivo bladder cancer diagnosis by high-volume Raman spectroscopy.
Ronald O.P. Draga (2010)
10.1016/j.juro.2009.06.039
Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy.
Geoffrey A. Sonn (2009)
10.1016/j.urology.2011.08.081
Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach.
Bogdan Florin Geavlete (2012)
10.1111/j.1464-410X.2011.10090.x
Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
Gregers Gautier Hermann (2011)
10.3322/canjclin.39.6.399
Cancer statistics.
N Dubrawsky (1989)
10.1016/S0022-5347(01)63691-7
The development of the cystoscope.
Matthias A. Reuter (1998)
10.1016/j.jclinepi.2013.03.003
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers.
Lisa Hartling (2013)
10.1016/j.urology.2005.07.062
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Ziya Kırkalı (2005)
10.1111/j.1464-410X.2004.05715.x
5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Marko Babjuk (2005)
with 5 - aminolevulinic acid - induced fluorescence cystoscopy : a multicenter randomized , double - blind , placebo - controlled trial
M Burger (2011)
10.1186/2193-1801-3-24
Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
Marcus Horstmann (2014)
10.1016/j.eururo.2014.06.049
Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
Harry W. Herr (2015)
10.3892/ijo.24.1.59
Laser-induced autofluorescence microscopy of normal and tumor human colonic tissue.
Zhiwei Huang (2004)
10.1016/j.gie.2013.12.005
Scanning fiber endoscopy: a novel platform for cholangioscopy.
Adam W. Templeton (2014)
10.1111/j.1464-410X.2011.10169.x
Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery.
Ashutosh K. Tewari (2011)
10.1016/j.urology.2006.12.023
Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Stefan Denzinger (2007)
10.1016/j.tibtech.2013.01.013
Surface-enhanced Raman scattering in cancer detection and imaging.
Marc Vendrell (2013)
10.1111/j.1464-410X.2012.11500.x
Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.
Changjian Zheng (2012)
10.1016/j.eururo.2013.06.003
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Marko Babjuk (2013)
10.1186/2046-4053-4-1
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher (2015)
10.1016/j.urology.2009.11.075
Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer.
Evelyne C. C. Cauberg (2010)
10.1089/end.2009.0598
Narrow-band imaging flexible cystoscopy: a new user's experience.
Richard T Bryan (2010)
10.1016/j.juro.2010.06.148
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
Arnulf Stenzl (2010)
10.1089/end.2014.1651
The Storz professional image enhancement system(spies) nonmuscle-invasive bladder cancer study:a multicenter international randomized controlled study.
Stavros Gravas (2014)
10.1016/j.ucl.2015.01.001
Advances in imaging technologies in the evaluation of high-grade bladder cancer.
Dimitar V Zlatev (2015)
10.1089/end.2011.1548
Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy
Katherine Wu (2011)
10.18632/oncotarget.13054
Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis
Weiting Kang (2017)
10.1016/j.eururo.2009.10.030
Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
Martin C. Schumacher (2010)
* Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer : A Systematic Review and Cumulative Analysis of Prospective Studies
Hopital Cantonal (2010)
10.1109/TBME.2012.2191783
Surface Mosaics of the Bladder Reconstructed From Endoscopic Video for Automated Surveillance
Timothy D. Soper (2012)
10.1016/j.eururo.2014.06.037
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
J. Alfred Witjes (2014)
10.1016/j.eururo.2009.11.041
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.
Ingo Kausch (2010)
10.1073/pnas.1114746108
Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue
David Rincón Rivera (2011)
10.1186/1471-2288-8-22
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
Andreas Lundh (2008)
10.1038/NPHOTON.2012.361
Advances in multiphoton microscopy technology.
Erich E. Hoover (2013)
10.1007/s00216-012-6424-6
Selective sampling using confocal Raman spectroscopy provides enhanced specificity for urinary bladder cancer diagnosis
Ishan Barman (2012)
10.1016/j.eururo.2016.05.041
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk (2017)
10.1097/01.ju.0000181814.73466.14
Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Dmitry Daniltchenko (2005)
10.1111/j.1365-2036.2009.04207.x
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract.
Michael B. Wallace (2010)
10.1016/j.juro.2013.01.100
Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study.
Christof Schaefauer (2013)
10.1177/097492849304900107
Statement
Amal Mudallali (1993)
10.1111/J.1464-410X.2007.07317.X
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder.
Richard T Bryan (2008)
10.1016/j.eururo.2013.03.059
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Maximilian Burger (2013)
10.1016/j.gie.2011.08.024
Diagnostic accuracy of probe-based confocal laser endomicroscopy in detecting residual colorectal neoplasia after EMR: a prospective study.
Muhammad Shahid (2012)
10.1017/S0266462310001364
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis.
Graham Mowatt (2011)
10.5858/arpa.2011-0147-oa
Multiphoton microscopy in the evaluation of human bladder biopsies.
Manu Jain (2012)
10.1089/end.2010.0686
Comparison of 2.6- and 1.4-mm imaging probes for confocal laser endomicroscopy of the urinary tract.
Winifred Adams (2011)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1111/j.1464-410X.2011.10374.x
Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Bogdan Florin Geavlete (2012)
10.1111/j.1464-410X.2008.07846.x
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
Harry W. Herr (2008)
History of cystoscopy.
Ferrin Jw (1947)
10.1590/S1677-55382011000500027
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial
A. Stenzl (2011)
10.1089/end.2010.0055
Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.
Katsunori Tatsugami (2010)



This paper is referenced by
10.1007/s00092-020-4119-4
Neue optische Verfahren in der Blase
Philippe-Fabian Pohlmann (2020)
10.1016/j.pdpdt.2020.101719
Evaluation of Autofluorescence and Photodynamic Diagnosis in Assessment of Bladder Lesions.
Kamil Bochynek (2020)
Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy.
Peter J. Davidson (2019)
10.1038/s41394-020-0302-9
Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder
Gianluca Sampogna (2020)
10.1007/s00405-020-06204-3
Use of IMAGE1 S technology for detection of cholesteatoma in endoscopic ear surgery: a retrospective case series on 45 patients
Daniela Lucidi (2020)
10.1055/A-0731-0008
Enhanced imaging – Neue diagnostische Methoden beim Urothelkarzinom
Thomas Knoll (2019)
10.1007/s10147-020-01654-5
A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables
Makito Miyake (2020)
10.1016/j.pdpdt.2019.05.036
Methods of bladder cancer diagnostics - the role of autofluorescence and photodynamic diagnosis.
Kamil Bochenek (2019)
10.1016/j.pdpdt.2020.101829
Two Diagnostic Criteria of Optical Spectroscopy for Bladder Tumor Detection: Clinical Study using 5-ALA induced fluorescence and Mathematical Modeling.
Nina Kalyagina (2020)
10.2147/RRU.S173027
Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
Makito Miyake (2018)
10.1177/1756287219833056
A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer
Julie Mariam Joshua (2019)
10.1002/tbio.201900026
Fluorescence Visualization of the Borders of Bladder Tumors After TUR with Quantitative Determination of Diagnostic Contrast
Maxim Loshchenov (2020)
10.1111/iju.13856
Transient liver toxicity as a result of the oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
Makito Miyake (2019)
Semantic Scholar Logo Some data provided by SemanticScholar